| |
Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery disease
Am J Cardiol, 2009. 103(11): p. 1518-24.
N. M. Allen LaPointe, et al., |
| |
Lessons learned from the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial
Am J Cardiol, 2009. 104(10 Suppl): p. 10E-5E.
P. Barter, |
| |
Plasma triglycerides and cardiovascular events in the Treating to New Targets and Incremental Decrease in End-Points through Aggressive Lipid Lowering trials of statins in patients with coronary artery disease
Am J Cardiol, 2009. 104(4): p. 459-63.
O. Faergeman, et al., |
| |
Antiplatelet therapy in patients with anticoagulants undergoing percutaneous coronary stenting (from STENTIng and oral antiCOagulants [STENTICO])
Am J Cardiol, 2009. 104(3): p. 338-42.
M. Gilard, et al., |
| |
Safety of selective serotonin reuptake inhibitor in adults undergoing coronary artery bypass grafting
Am J Cardiol, 2009. 103(10): p. 1391-5.
D. H. Kim, et al., |
| |
Impact of homocysteine-lowering vitamin therapy on long-term outcome of patients with coronary artery disease
Am J Cardiol, 2009. 104(6): p. 745-9.
A. Mager, et al., |
| |
Acute effects of statin therapy on coronary atherosclerosis following an acute coronary syndrome
Am J Cardiol, 2009. 104(6): p. 750-7.
J. Rodes-Cabau, et al., |
| |
High-density lipoprotein cholesterol as a risk factor and target of therapy after acute coronary syndrome
Am J Cardiol, 2009. 104(10 Suppl): p. 46E-51E.
G. G. Schwartz, |
| |
Safety and tolerability of dalcetrapib
Am J Cardiol, 2009. 104(1): p. 82-91.
E. A. Stein, et al., |
| |
Association of leukocyte subtype counts with coronary atherosclerotic regression following pravastatin treatment
Am J Cardiol, 2009. 104(4): p. 464-9.
S. Tani, et al., |
| |
Comparison of bivalirudin monotherapy versus unfractionated heparin plus tirofiban in patients with diabetes mellitus undergoing elective percutaneous coronary intervention
Am J Cardiol, 2009. 104(9): p. 1222-8.
D. Tavano, et al., |
| |
Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease
Am J Cardiol, 2009. 104(6): p. 798-804.
H. Teoh, et al., |
| |
Safety and efficacy of achieving very low low-density lipoprotein cholesterol levels with rosuvastatin 40 mg daily (from the ASTEROID Study)
Am J Cardiol, 2009. 104(1): p. 29-35.
S. D. Wiviott, et al., |
| |
Impact of bivalirudin on in-hospital bleeding and six-month outcomes in octogenarians undergoing percutaneous coronary intervention
Catheter Cardiovasc Interv, 2009. 74(3): p. 428-35.
G. Lemesle, et al., |
| |
Long-term mortality after bolus-only administration of abciximab, eptifibatide, or tirofiban during percutaneous coronary intervention
Catheter Cardiovasc Interv, 2009. 73(2): p. 214-21.
J. D. Marmur, et al., |
| |
Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction
Circulation, 2009. 119(9): p. 1195-202.
S. Cheng, et al., |
| |
Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study
Eur Heart J, 2009. 30(3): p. 314-20.
T. Keller, et al., |
| |
A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study
Eur Heart J, 2009. 30(13): p. 1590-7.
T. F. Luscher, et al., |
| |
Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures
J Am Coll Cardiol, 2009. 54(24): p. 2261-76.
R. C. Becker, et al., |
| |
Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial
J Am Coll Cardiol, 2009. 54(6): p. 558-65.
G. Di Sciascio, et al., |
| |
Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study)
J Am Coll Cardiol, 2009. 54(4): p. 293-302.
T. Hiro, et al., |
| |
Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction
JAMA, 2009. 302(8): p. 866-73.
A. Nanda, et al., |
| |
| |
| |
 |